Menu

Breast Cancer

June 27, 2022 | AONN+ Blog
Breast Cancer
For patients with breast cancer who need surgery, we should encourage them to think this way—“when you look down, don’t see that your breast is gone; see instead that the cancer is gone.”
Adolescent and young adult survivors of breast cancer may face many of the same challenges as other cancer survivors, but some concerns, such as childcare and infertility, are especially salient for them.
A recent AONN+ annual conference session discussed an FDA-approved PET imaging agent, which is used as an adjunct to biopsy for the detection of estrogen receptor (ER)-positive lesions to help inform treatment selection for patients with recurrent or metastatic breast cancer.
October 22, 2021 | AONN+ Blog
Breast Cancer
Female hormones serve as fuel for more than 70% of breast cancers. This is important to consider when meeting patients who may be taking female hormones.
October 18, 2021 | AONN+ Blog
Breast Cancer
Breast cancer treatment has come a long way, offering more options to ensure the patient isn’t forfeiting anything to their cancer.
Yale University researchers say a community-based, collaborative oncology navigation approach works better than primarily hospital-based services in helping underserved minority women with breast cancer.
September 23, 2021 | AONN+ Blog
Breast Cancer
In episode 15 of the AONN+ Heart and Soul of Oncology Navigation podcast, experts discuss Living Beyond Breast Cancer’s Needs Assessment of Young Women Diagnosed with Breast Cancer and how oncology navigators can learn from these findings.
September 13, 2021 | AONN+ Blog
Breast Cancer
Some studies suggest that a breast cancer diagnosis correlates with divorce rates. Oncology navigators can assist patients who may be experiencing relationship troubles by keeping an open line of communication.
2019 ONE Award winner Susie Ulloa discusses how her experience as a breast cancer survivor has influenced how she navigates her patients.
NeuVax + Herceptin may provide a clinically meaningful benefit to breast cancer patients with low to intermediate HER2-expression.
Page 1 of 3
Results 1 - 10 of 29

Thank You to Our Corporate Sponsors and Alliance Partners!

  • Patron Corporate Sponsor

    Patron Corporate Sponsor

  • Patron Corporate Sponsor

    Patron Corporate Sponsor

  • Patron Corporate Sponsor

    Patron Corporate Sponsor

  • National Alliance Partner

    National Alliance Partner

  • Patron Corporate Sponsor

    Patron Corporate Sponsor

  • Patron Corporate Sponsor

    Patron Corporate Sponsor

  • Patron Corporate Sponsor

    Patron Corporate Sponsor

  • Industry Relations Council Member

    Industry Relations
    Council Member

  • Industry Relations Council Member

    Industry Relations
    Council Member

  • National Alliance Partner

    National Alliance Partner

  • National Alliance Partner

    National Alliance Partner